Chapman Investment Management’s Eli Lilly LLY Stock Holding History

Chapman Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,457	Closed	-$3.53M	–	41
2026 Q1	$3.18M	Sell	3,457 -34	-1%	-$34.5K	2.62%	13
2025 Q4	$3.75M	Buy	3,491 +5	+0.1%	+$4.78K	2.74%	14
2025 Q3	$2.66M	Buy	3,486 +397	+13%	+$295K	1.89%	17
2025 Q2	$2.41M	Buy	3,089 +50	+2%	+$38.9K	1.68%	18
2025 Q1	$2.51M	Buy	3,039 +11	+0.4%	+$9.15K	1.87%	17
2024 Q4	$2.34M	Buy	3,028 +218	+8%	+$181K	1.74%	18
2024 Q3	$2.49M	Buy	2,810 +4	+0.1%	+$3.6K	1.82%	18
2024 Q2	$2.54M	Buy	2,806 +111	+4%	+$88.8K	1.93%	19
2024 Q1	$2.1M	Buy	+2,695	New	+$1.92M	1.54%	20

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Chapman Investment Management's LLY Position: Q2 2026 in Review

Chapman Investment Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,457 shares — an estimated $3.53M sold.

Chapman Investment Management first reported a position in LLY in Q1 2024 and held it in 9 quarters. The position peaked at $3.75M in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Chapman Investment Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Chapman Investment Management sold 3,457 Eli Lilly shares in Q2 2026, an estimated $3.53M.
Chapman Investment Management first reported a position in Eli Lilly in Q1 2024 and held it in 9 quarters.
Chapman Investment Management's Eli Lilly position peaked at $3.75M in Q4 2025.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chapman Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.